Cancer Prevention and Control Program
Cancer Prevention and Control Program
批准号:
10599088
负责人:
RICHARD D SCHULICK
金额:
$2.97万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-04-04 至 2027-01-31
关键词:
AccelerationAddressAgingAntineoplastic AgentsAreaAwardBasic ScienceBehavioralBehavioral SciencesBioinformaticsBiometryBreastCancer BurdenCancer Center Support GrantCancer ControlCancer SurvivorshipCaregiversCatchment AreaChemopreventionChemopreventive AgentClinicClinicalClinical Practice VariationsClinical ResearchClinical TrialsCollaborationsColoradoColorectalCommunicationCommunitiesCommunity OutreachData SourcesDiagnosisDisparityDysplasiaEarly DiagnosisEconomicsElderlyElementsEnvironmental ExposureEpidemiologic MethodsEthnic OriginEvidence based practiceExposure disparityFamily CaregiverFlow CytometryFosteringFundingFutureGenomicsGoalsGrantGrowthHead and Neck CancerHealthHealth Disparities ResearchHealth Services ResearchHispanic PopulationsHuman Papilloma Virus VaccineIndividualInstitutionInterventionInvestigationJournalsLaboratoriesLeadershipLinkLungMalignant NeoplasmsMalignant neoplasm of lungMedicalMentorsMetabolismMissionMonitorNCI-Designated Cancer CenterOncologyOutcomePalliative CarePancreasPathologyPatient CarePatternPeer Review OrganizationsPersonal SatisfactionPharmacy SchoolsPhysical activityPlayPoliciesPolicy ResearchPreventionPrevention approachPsychologistPublic HealthPublicationsPublishingQuality of lifeRaceResearchResearch Peer ReviewResearch PersonnelResearch Project GrantsResource SharingResourcesRiskRisk FactorsRisk ReductionRoleRuralSchoolsScienceScientistScreening for cancerSeriesSocioeconomic StatusStrategic PlanningSupportive careTrainingTraining and EducationTranslatingTranslationsTreatment outcomeUnited States National Institutes of HealthUniversitiesWorkanticancer researchbiobankcancer carecancer health disparitycancer preventioncancer riskcareerclinical practicecommunity engagementcommunity settingdisparity reductionepidemiology studyexperiencefrontierhealth disparityhealth equityhealth inequalitiesimplementation scienceimprovedimproved outcomeinnovationlung cancer screeningmedical schoolsmelanomamembernovel strategiesnutritionpopulation basedpopulation healthprofessorprogramsreconstitutionrecruitresidencerural dwellersstress reductionsurvivorshipuptakeurban disparity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Overview and Goals: The goal of the CPC program is to apply the expertise of behavioral, basic, and clinician
scientists to conduct innovative and impactful cancer research that reduces Colorado's cancer burden. Program
members work to improve population health, change clinical practice, and improve outcomes with a focus on
approaches that reduce disparities associated with race/ethnicity, socioeconomic status, and rural/frontier
residence. CPC brings together outstanding transdisciplinary, well-funded scientists with strengths from basic
science through public health. Research Highlights: CPC conducts innovative and impactful research across
many cancers, including lung, breast, colorectal, melanoma, and pancreatic relevant to cancer burden and
disparities within the catchment. Using lung cancer research examples from each program aim, CPC members
pioneered a chemoprevention approach to reverse endobronchial dysplasia (Aim 1). CPC members
demonstrated the efficacy of a novel approach to improve quality of life and well-being among individuals
diagnosed with lung and head/neck cancer (Aim 2). Leveraging the Population Health Shared Resource (PHSR),
CPC members identified significant rural-urban disparities in uptake of innovative antineoplastic agents for
metastatic lung cancer, demonstrating CPC expertise in health disparities research (Aim 3). Program Activities:
CPC co-leaders, Agarwal and Studts, utilize support provided by UCCC to host annual retreats, monthly
seminars, and ad hoc mini-retreats to facilitate intra- and inter-programmatic collaborations. Programmatic
funding also supports pilot grants for mentored members and stimulates research in targeted areas that align
with the catchment and health disparities. Members: The program has 41 Full and 13 mentored members with
$2.8M NCI and $3.9M of other cancer peer-reviewed research grant funding in 2020. Members are from 34
departments and 6 schools, and most members hold primary affiliations with University of Colorado Anschutz
Medical Campus (UCAMC), University of Colorado Boulder (UCB) and Colorado State University (CSU). CPC
members published 494 cancer-focused publications in 2016-2020, 13% published in journals with an impact
factor ≥10, and 33% published in journals with an impact factor of ≥5. With extensive collaborations across
programs, 216 (44%) of CPC publications were either inter-programmatic (29%), intra-programmatic (20%) or
both (5%); and 167 (34%) constitute collaborations with other NCI-designated cancer center members. Future
Directions: In concert with the UCCC strategic plan, CPC leadership seeks to accelerate the CPC growth
trajectory in scientific impact, collaboration, research, community engagement, and training. CPC will pursue five
specific future directions related to (1) translating and expanding chemoprevention; (2) escalating clinical
research in behavioral oncology; (3) enhancing health equity research; (4) enriching implementation science in
cancer and (5) expanding graduate and post-graduate training in rural and frontier cancer prevention and control.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Colorado Cancer Center Support Grant
-
批准号:10371494
-
项目类别:
-
资助金额:$11.5万
-
财政年份:2021
-
负责人:RICHARD D SCHULICK
-
依托单位:
University of Colorado Cancer Center Support Grant - CTRAC Supplement Yr 02
-
批准号:10439981
-
项目类别:
-
资助金额:$8.25万
-
财政年份:2021
-
负责人:RICHARD D SCHULICK
-
依托单位:
Colorado's Partnership to Implement Evidence-Based Interventions to Reduce the Cancer Burden
-
批准号:10409393
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2021
-
负责人:RICHARD D SCHULICK
-
依托单位:
Interferon Signaling and the Differential Malignancy Spectrum of Down Syndrome
-
批准号:9933418
-
项目类别:
-
资助金额:$46.16万
-
财政年份:2019
-
负责人:RICHARD D SCHULICK
-
依托单位:
Listeria Monocytogenes to Treat Hepatic Metastases
-
批准号:6988218
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2005
-
负责人:RICHARD D SCHULICK
-
依托单位:
Listeria Monocytogenes to Treat Hepatic Metastases
-
批准号:7228884
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2005
-
负责人:RICHARD D SCHULICK
-
依托单位:
Listeria Monocytogenes to Treat Hepatic Metastases
-
批准号:7085533
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2005
-
负责人:RICHARD D SCHULICK
-
依托单位:
Listeria Monocytogenes to Treat Hepatic Metastases
-
批准号:7406622
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2005
-
负责人:RICHARD D SCHULICK
-
依托单位:
Listeria Monocytogenes to Treat Hepatic Metastases
-
批准号:7590470
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2005
-
负责人:RICHARD D SCHULICK
-
依托单位:
GM-CSF Enhanced Colorectal Cancer Tumor Vaccine Program
-
批准号:6945464
-
项目类别:
-
资助金额:$14.01万
-
财政年份:2004
-
负责人:RICHARD D SCHULICK
-
依托单位:
GM-CSF Enhanced Colorectal Cancer Tumor Vaccine Program
-
批准号:7477966
-
项目类别:
-
资助金额:$14.01万
-
财政年份:2004
-
负责人:RICHARD D SCHULICK
-
依托单位:
GM-CSF Enhanced Colorectal Cancer Tumor Vaccine Program
-
批准号:7111018
-
项目类别:
-
资助金额:$14.01万
-
财政年份:2004
-
负责人:RICHARD D SCHULICK
-
依托单位:
GM-CSF Enhanced Colorectal Cancer Tumor Vaccine Program
-
批准号:6707302
-
项目类别:
-
资助金额:$13.93万
-
财政年份:2004
-
负责人:RICHARD D SCHULICK
-
依托单位:
Developmental Funds
-
批准号:10332916
-
项目类别:
-
资助金额:$11.93万
-
财政年份:1997
-
负责人:RICHARD D SCHULICK
-
依托单位:
Cancer Research Training and Education Coordination
-
批准号:10332909
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1997
-
负责人:RICHARD D SCHULICK
-
依托单位:
Leadership, Planning and Evaluation
-
批准号:10332914
-
项目类别:
-
资助金额:$39.34万
-
财政年份:1997
-
负责人:RICHARD D SCHULICK
-
依托单位:
Cancer Research Training and Education Coordination
-
批准号:10599086
-
项目类别:
-
资助金额:$3.79万
-
财政年份:1997
-
负责人:RICHARD D SCHULICK
-
依托单位:
Genomics Shared Resource
-
批准号:10599162
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1997
-
负责人:RICHARD D SCHULICK
-
依托单位:
Human Immune Monitoring Shared Resource
-
批准号:10599165
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1997
-
负责人:RICHARD D SCHULICK
-
依托单位:
Molecular and Cellular Oncology Program
-
批准号:10599102
-
项目类别:
-
资助金额:$2.84万
-
财政年份:1997
-
负责人:RICHARD D SCHULICK
-
依托单位:
海外基金